Gym or Raking Leaves?

How important is rigorous gym exercise versus ordinary work day exercise/tasks? New research at Oregon State University suggests the health benefits of small amounts of activity — even as small as one- and two-minute increments that add up to 30 minutes per day — can be just as beneficial as longer periods of physical exercise achieved by a trip to the gym. The nationally representative study of …

Canada’s Flaherty reveals skin disease, explains bloating

Canada's Finance Minister Flaherty speaks during a news conference on Parliament Hill in OttawaOTTAWA (Reuters) – Canadian Finance Minister Jim Flaherty revealed on Thursday he is suffering from a serious skin disease and is taking steroids that make him appear bloated and red-faced, but that the problem is not preventing him from doing his job. Flaherty's health has been a source of speculation in Ottawa for months because of his changed appearance. The minister, 63, has had the rare condition, called bullous pemphigoid, for nearly a year, his office said in a statement. …

New AstraZeneca CEO plans to invest through tough year

LONDON (Reuters) – AstraZeneca’s new boss said sales and profits would both fall sharply in 2013 as the drugmaker struggles to turn itself around by investing more in-house and on potential acquisitions. Chief Executive Pascal Soriot forecast a mid-to-high single digit percentage fall in revenue this year, as patent expiries continue to erode business, with earnings declining “significantly more” due to increased operating costs. The 2013 outlook was worse than the fall of around 3 percent in sales that analysts had been expecting, and shares in the group slumped 5.4 percent by 6:50 a.m. …

Vanda to stop developing anti-depressant, shares slip

(Reuters) – Vanda Pharmaceuticals Inc said it would stop developing its experimental drug for major depressive disorder after it failed to meet the main goal of improving symptoms in patients in a clinical trial, sending its shares down about 8 percent. The company said patients treated with the drug tasimelteon and those on a placebo showed about a 40 percent reduction in symptoms, based on a standard scale that measures severity of depression. The trial, named Magellan, enrolled 507 patients in 43 sites in the United States, and was comparing a 20mg dose of the drug with a placebo. …

1 885 886 887 888 889 977